References
- Turnbull PCB, Kramer JM. Bacillus. In: Balows A, Hausier WJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology, 5th edn. Washington, DC: ASM Press, 1991: 296–303.
- Gold H. Anthrax: a report of one hundred seventeen cases. Arch Intern Med 1995; 96: 387–96.
- Swartz MN. Recognition and management of anthrax – an update. N Engl J Med 2001; 345: 1621–6.
- Doğanay M, Aydin N. Antimicrobial susceptibility of Bacillus anthracis. Scand J Infect Dis 1991; 23: 333–5.
- Lightfoot NF, Scott RJD, Turnbull PCB. Antimicrobial susceptibility of Bacillus anthracis. Salisbury Med Bull 1990; 68 (Suppl): S95–8.
- Bradaric N, Punda-Polic V. Cutaneous anthrax due to penicillin-resistant Bacillus anthracis transmitted by an insect bite. Lancet 1992; 340: 306–7.
- Lalitha MK, Thomas MK. Penicillin resistance in Bacillus anthracis. Lancet 1997; 349: 1522.
- Doganay M, Almac A, Hanagasi R. Primary throat anthrax. Scand J Infect Dis 1986; 18: 415–9.
- Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 2001; 50: 909–19.
- Doganay M. Human anthrax in Sivas, Turkey. Salisbury Med Bull 1990; 68 (Suppl): S13.
- Woodall J. The Soviet bioweapons programme: an insider’s view. Lancet 1999; 354: 1868–9.
- Brook I, Elliott TB, Pryor HI, Sautter TE, Gnade BT, Thakar JH, et al. In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones. Int J Antimicrob Agents 2001; 18: 559–62.
- Choe CH, Bouhaouala SS, Brook I, Elliott TB, Knudson GB. In vitro development of resistance to ofloxacin and doxycy- cline in Bacillus anthracis Sterne. Antimicrob Agents Chemother 2000; 44: 1766.
- Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, et al. Anthrax as a biological weapon: medical and public health management. JAMA 1999; 281: 1735–45.
- Heddurshetti R, Pumpradit W, Lutwick LI. Pulmonary manifestations of bioterrorism. Curr Infect Dis Rep 2001; 3: 249–57.
- Sumerkan B, Aygen B, Doganay M, Sehmen E. Antimicrobial susceptibility of Bacillus anthracis against macrolides. Salisbury Med Bull 1995; 87 (Suppl): S138.